U.S. License Holder:
AbbVie
Date of License:
April-30-2009
Last Update:
Nov-15-2023
FDA-Approved Indications
CREON (pancrelipase (amylase; lipase; protease)) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.